Ryan C.N. D'Arcy (born 1972) is a Canadian neuroscientist, researcher, innovator and entrepreneur. D'Arcy co-founded HealthTech Connex Inc. where he serves as President and Chief Scientific Officer. HealthTech Connex translates neuroscience advancements into health technology breakthroughs. D'Arcy is most known for coining the term "brain vital signs" and for leading the research and development of the brain vital signs framework. [1]
He is also a full tenured professor with appointments at both Simon Fraser University and the University of British Columbia. He holds the Surrey Memorial Hospital Foundation BC Leadership Chair in Multimodal Technology for Healthcare Innovations. [2] D'Arcy has published more than 300 academic works, generated more than $100 million in competitive research and innovation investment, and has been recognized through numerous national and international awards and distinctions. [3]
Throughout his career, D'Arcy has been advancing brain innovations. He constantly champions Canada's role in the world's neuroscience sphere. [4] He has been advocating for the brain to be monitored regularly to track one's health, as you would monitor other vital signs of the body. [5] He is strongly focused on optimizing brain health through objective measurements to find the best treatments. His work has involved developing accessible technology improvements for evaluation and treatment in brain injury and concussion, along with other brain conditions such as dementia, epilepsy, brain tumours and stroke. [6]
D'Arcy has played instrumental roles in advancing Canada's biotechnology industry through founding and co-founding a number of large-scale health-technology initiatives over the course of his career while at the National Research Council Canada (NRC) and Simon Fraser University/Surrey Memorial Hospital. These initiatives include NRC's Institute of Biodiagnostics (Atlantic), now called BIOTIC, and BC's Health and Technology District, encompassing Surrey Memorial Hospital's Health Sciences and Innovation initiative, Innovation Boulevard, [7] the NeuroTech [8] and ImageTech Laboratories, the HealthTech Innovation Hub and the BrainNET initiative. The Health and Technology District continues to grow towards the planned goals of over 1.5 million square feet of health/technology/innovation space, employing more than 15,000 tech and tech related jobs, and generating more than $1.1 billion into the economy annually. [9]
Born and raised in Williams Lake, British Columbia, Ryan D'Arcy attended Brentwood College School, on Vancouver Island, graduating in 1990. He earned a B.Sc. (with distinction) from the University of Victoria in 1996, an M.Sc. in neuropsychology in 1998 and a Ph.D. in neuroscience in 2002 from Dalhousie University. D'Arcy was a Killam Scholar while at Dalhousie University. [10] In 2001, he moved to NRC’s Institute for Biodiagnostics for a Research Associate/Postdoctoral Fellowship in Magnetic Resonance Imaging Physics. [7] He is a member of the Professional Engineers and Geoscientists of British Columbia, as an engineering licensee (PlEng) with a specialization in neuroimaging and neurotechnology.
Foundational research that led to the concept of brain vital signs started in 1995, with Dr. D’Arcy leading the development of the first rapid, easy, point-of-care measurement of brain waves in 2011. [11] The objective was to utilize electroencephalography (EEG) data, and particularly cognitive evoked potentials (EPs), also known as event-related potentials (ERPs), as an objective physiological measure of brain function. ERPs were well established but had not been translated into a clinically accessible framework in a manner similar to the measurement of a body's vital signs like blood pressure. [5] D’Arcy’s team developed a new brain vital sign [1] framework specific to the evaluation and monitoring of brain function. The brain vital signs framework, which derived from the earlier Halifax Consciousness Scanner work, objectively analyze complex EEG data, which then provides simple and objective physiological markers of brain function. [1]
The research team subsequently published a series of studies on the development of brain vital signs. These included the Frontiers in Neuroscience Journal, which remains the most highly accessed paper in the journal's history and ranked in the top 5% of research outputs scored by Altmetrics, [1] and findings from a multi-year hockey concussion study conducted in collaboration with the Mayo Clinic Sports Medicine Center in Brain: A Journal of Neurology. [12] The latter study was the first to demonstrate that brain vital sign monitoring is more sensitive in detecting impairments than existing clinical tests for concussions.
In 2013, D’Arcy and Kirk Fisher co-founded HealthTech Connex Inc. Derived from the brain vital sign science, HealthTech Connex conceived the NeuroCatch Platform to convert electroencephalography recordings (EEG) of the N100 (Auditory sensation), P300 (Basic attention), and N400 (Cognitive processing) into a rapid, portable, non-invasive evaluation platform for point-of-care deployment.
D'Arcy also co-founded the Health and Technology District with Lark Group, a Canadian family-owned and operated development, construction and facility management company based in Surrey, British Columbia. The Health and Technology District is a rapidly growing and dynamic new health tech sector located in the heart of Surrey’s emerging innovation ecosystem. [13] The District includes a series of high-tech buildings located and under expansion, directly adjacent to Surrey Memorial Hospital, one of Canada's busiest hospitals. [14]
The District is a unique cluster of large, multinational and start-up companies, international partners, clinical and research facilities, scientists, innovators, and entrepreneurs. It is also where an abundance of healthcare environments, patients and clinicians are co-located, working in partnership to accelerate the implementation of technologies and solutions towards health care impacts and improvements.
The Lark Group developed the Health and Technology District in anticipation of the rapidly growing health and technology sector in British Columbia. The District currently consists of three buildings, City Centre 1, 2, [15] and 3, [16] with the largest City Centre 4 breaking ground in 2022 and is slated to be completed in 2025. [17]
In 2019, D'Arcy spearheaded the formation of BrainNET within the Health and Technology District, a clinical-academic-innovation network dedicated to bringing advances in neuro-technologies to individual improvements in brain health through a consortium of initiatives and technologies.
D’Arcy has been credited in helping translate neuroscience advances into real-life impacts.
In the early 1990s, using functional MRI to detect white matter was considered controversial, despite it being traditionally used for gray brain matter. Dr. D’Arcy and a team of researchers set out to investigate white matter fMRI activation, and published a number of studies with evidence to support using fMRI for white matter activation. These studies opened up fundamental avenues to explore functional connectivity in distributed neural networks, which has since been used to advance understanding of white matter dysfunction in neurological diseases such as multiple sclerosis and Alzheimer’s disease. [18]
Since 1995, D’Arcy and his research team have led the development of using event-related potentials (ERPs) for clinical evaluations of brain function. In 2010, they developed the Halifax Consciousness Scanner (HCS), a portable ERP device that quickly determines neurological function in cases of severe brain trauma. [19] The HCS technology was widely recognized with several innovation awards, including the 2015 Winner of Wall Street Journal’s Global Technology Start-up Showcase. [20] While developed for functional status evaluation, the HCS prototype ultimately led to the discovery of the brain vital signs framework, which has since led the development the NeuroCatch Platform through HealthTech Connex. The NeuroCatch Platform received its first regulator approval as a Class II Medical Device from Health Canada in early 2019. [21]
In 2008, together with neuroscientist and neurosurgeon Dr. David B. Clarke, D'Arcy was part of the research team at the National Research Council at Dalhousie University in developing the world's first virtual reality based neurosurgical simulation and rehearsal tool NeuroTouch, which was subsequently licensed to CAE Inc. as NeuroVR. [22] [23] [24] Subsequently, D'Arcy and Clarke teamed up again, this time with Conquer Mobile to develop PeriopSim, a suite of portable surgical simulation training tools used to train perioperative nurses. [25]
D’Arcy was involved with Simon Fraser University's rapid growth in medical technology research, one component of which is the launch of the ImageTech Lab. [26] The SFU ImageTechLab is a first-of-its-kind research facility in Western Canada, combining state-of-the-art imaging devices to advance brain/body research, and focus on advanced diagnostics and treatment in neurology, mental health and other healthcare areas. The ImageTech Lab completed the large-scale initiative announced April 2013 by then City of Surrey Mayor Dianne Watts to create the Mayor's Health Technology Working Group with D’Arcy as co-chair. It composed of leaders from the health, education, and development communities to shape a new health-tech region located between Simon Fraser University Surrey and Surrey Memorial Hospital called Innovation Boulevard. [7]
Since 2009, D’Arcy has been helping rehabilitate Trevor Greene, a Canadian war veteran and brain injury survivor who was attacked while on tour in Afghanistan with an axe to the head. [27] D'Arcy, together with Trevor and his wife Debbie Greene, have used different modalities to support recovery through the use of brain imaging, assistive device, and neuromodulation technologies paired with intensive rehabilitation. [28] [29] The project (called “Iron Soldier”) has since progressed towards Trevor's goal to climb to the Mount Everest base camp, and catalyzed the Legion Veteran's Village initiative to revitalize Legions across the country into centres for excellence in rehabilitation and post-traumatic stress disorder. [30]
D’Arcy and his research team at HealthTech Connex Inc. and the Surrey Neuroplasticity Clinic in Surrey, B.C., continued to help Greene with intensive daily rehabilitation, but the team experienced an extended plateau in progress using conventional therapy alone. To break through the plateau, the research team launched an intensive 14-week study using the Portable Neuromodulation Stimulator (or PoNS™), in combination with physical therapy to safely stimulate novel neuroplasticity and tracked brain vital sign improvements using the NeuroCatch® Platform (or NeuroCatch®). The peer-reviewed study on Capt. Greene’s physical, cognitive and PTSD improvements was published in September 2020 in the Frontiers of Human Neuroscience, [31] demonstrating that the PoNS neurostimulation, paired with intensive rehabilitation, may stimulate neuroplasticity to overcome an extended recovery plateau in this case as objectively measured by NeuroCatch and other brain scanning technologies. [32]
As a thought leader, university professor and international speaker, Dr. D’Arcy speaks frequently to large audiences and has done so extensively over the course of his career. He has focused on communicating technology and scientific advances outside of academic and technical scientific forums. He is a 3-times TEDx speaker including Surrey’s TEDxBearCreekPark, [33] TEDxSFU and TEDxBrentwoodCollegeSchool, and has frequently represented Canada in health technology innovation events throughout the world, including leading brain technology missions around the world for over a decade. [34]
D'Arcy has been named one of Business in Vancouver's 2021, 2022, and 2023 BC500 leaders, recognizing the 500 most influential business leaders in British Columbia. [35]
In 2021, D'Arcy was named Business Person of the Year at the 2021 Surrey Board of Trade, Surrey Business Excellence Award. [36]
D'Arcy has been awarded a Public Service Award of Excellence, The National Research Council's Research Breakthrough of the Year, and the Discovery Award for Innovation. [37] [38]
D’Arcy's team was awarded the International Global Best Award in STEM in 2016 (Science, Technology, Engineering, and Mathematics). [39]
D'Arcy's HealthTech Connex Inc. team won a 2018 Surrey Business Excellence Award from the Surrey Board of Trade.
D'Arcy's published works include:
Simon Fraser University (SFU) is a public research university in British Columbia, Canada, with three campuses, all in Greater Vancouver: Burnaby, Surrey, and Vancouver. The 170-hectare (420-acre) main Burnaby campus on Burnaby Mountain, located 15 kilometres (9.3 mi) from downtown Vancouver, was established in 1965 and comprises more than 30,000 students and 160,000 alumni. The university was created in an effort to expand higher education across Canada.
Brodmann area 9, or BA9, refers to a cytoarchitecturally defined portion of the frontal cortex in the brain of humans and other primates. Its cytoarchitecture is referred to as granular due to the concentration of granule cells in layer IV. It contributes to the dorsolateral and medial prefrontal cortex.
Neuroscience and intelligence refers to the various neurological factors that are partly responsible for the variation of intelligence within species or between different species. A large amount of research in this area has been focused on the neural basis of human intelligence. Historic approaches to studying the neuroscience of intelligence consisted of correlating external head parameters, for example head circumference, to intelligence. Post-mortem measures of brain weight and brain volume have also been used. More recent methodologies focus on examining correlates of intelligence within the living brain using techniques such as magnetic resonance imaging (MRI), functional MRI (fMRI), electroencephalography (EEG), positron emission tomography and other non-invasive measures of brain structure and activity.
Neuromarketing is a commercial marketing communication field that applies neuropsychology to market research, studying consumers' sensorimotor, cognitive, and affective responses to marketing stimuli. The potential benefits to marketers include more efficient and effective marketing campaigns and strategies, fewer product and campaign failures, and ultimately the manipulation of the real needs and wants of people to suit the needs and wants of marketing interests.
Dr. Christopher deCharms is a neuroscientist, author, and inventor. Currently, Dr. deCharms is the founder and CEO of Brainful, a life-sciences companies focused on neurotechnology, including technology based on imaging methods that allow people to watch the activation of their own brains 'live' using functional magnetic resonance imaging (fMRI).
Connectomics is the production and study of connectomes: comprehensive maps of connections within an organism's nervous system. More generally, it can be thought of as the study of neuronal wiring diagrams with a focus on how structural connectivity, individual synapses, cellular morphology, and cellular ultrastructure contribute to the make up of a network. The nervous system is a network made of billions of connections and these connections are responsible for our thoughts, emotions, actions, memories, function and dysfunction. Therefore, the study of connectomics aims to advance our understanding of mental health and cognition by understanding how cells in the nervous system are connected and communicate. Because these structures are extremely complex, methods within this field use a high-throughput application of functional and structural neural imaging, most commonly magnetic resonance imaging (MRI), electron microscopy, and histological techniques in order to increase the speed, efficiency, and resolution of these nervous system maps. To date, tens of large scale datasets have been collected spanning the nervous system including the various areas of cortex, cerebellum, the retina, the peripheral nervous system and neuromuscular junctions.
The National Core for Neuroethics at the University of British Columbia was established in August 2007, with support from the Canadian Institutes of Health Research, the Institute of Mental Health and Addiction, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the Canada Research Chairs program, the UBC Brain Research Centre and the UBC Institute of Mental Health. Co-founded by Judy Illes and Peter Reiner, the Core studies neuroethics, with particular focus on ethics in neurodegenerative disease and regenerative medicine, international and cross-cultural challenges in brain research, neuroimaging and ethics, the neuroethics of enhancement, and personalized medicine.
Neurosecurity has been defined as "a version of computer science security principles and methods applied to neural engineering", or more fully, as "the protection of the confidentiality, integrity, and availability of neural devices from malicious parties with the goal of preserving the safety of a person’s neural mechanisms, neural computation, and free will". Simply put, Neurosecurity is, at least in principle, an antivirus and firewall for the mind. Neurosecurity also refers to the application of neuroscience to behavioral information security to better understand and improve users' security behaviors. Neurosecurity is a distinct concept from neuroethics; neurosecurity is effectively a way of enforcing a set of neuroethical principles for a neural device. Neurosecurity is also distinct from the application of neuroscience to national security, a topic that is addressed in Mind Wars: Brain Research and National Defense by Jonathan D. Moreno.
SFU's Beedie School of Business is the business school at Simon Fraser University (SFU) with multiple campuses across the Lower Mainland in British Columbia, Canada. Simon Fraser University was founded in 1965 and by 1982, the business discipline had grown to sufficient size to become its own distinct faculty, and the Bachelor of Business Administration (BBA) degree was established. In 2022, SFU Beedie celebrates its 40th anniversary.
The Human Connectome Project (HCP) is a five-year project sponsored by sixteen components of the National Institutes of Health, split between two consortia of research institutions. The project was launched in July 2009 as the first of three Grand Challenges of the NIH's Blueprint for Neuroscience Research. On September 15, 2010, the NIH announced that it would award two grants: $30 million over five years to a consortium led by Washington University in St. Louis and the University of Minnesota, with strong contributions from University of Oxford (FMRIB) and $8.5 million over three years to a consortium led by Harvard University, Massachusetts General Hospital and the University of California Los Angeles.
Anders Martin Dale is a prominent neuroscientist and professor of radiology, neurosciences, psychiatry, and cognitive science at the University of California, San Diego (UCSD), and is one of the world's leading developers of sophisticated computational neuroimaging techniques. He is the founding Director of the Center for Multimodal Imaging Genetics (CMIG) at UCSD.
Resting state fMRI is a method of functional magnetic resonance imaging (fMRI) that is used in brain mapping to evaluate regional interactions that occur in a resting or task-negative state, when an explicit task is not being performed. A number of resting-state brain networks have been identified, one of which is the default mode network. These brain networks are observed through changes in blood flow in the brain which creates what is referred to as a blood-oxygen-level dependent (BOLD) signal that can be measured using fMRI.
The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.
The following outline is provided as an overview of and topical guide to brain mapping:
The Brain Mapping Foundation is a neuroscience organization established in 2004 by Babak Kateb to advance cross-pollination of ideas across physical sciences into biological sciences and neuroscience. The organization provides funding to the members of the Society for Brain Mapping and Therapeutics (SBMT). One of the focuses of the foundation is to further establish and fund the National Center for NanoBioElectronics (NCNBE) to rapidly integrate nanotechnology, devices, imaging, cellular and stem cell therapy. The organization has played a significant role in President Obama's BRAIN initiative.
John-Dylan Haynes is a British-German brain researcher.
Neuro-Information-Systems (NeuroIS) is a subfield of the information systems (IS) discipline, which relies on neuroscience and neurophysiological knowledge and tools to better understand the development, use, and impact of information and communication technologies. The field has been formally established at the International Conference on Information Systems (ICIS) in 2007.
Patrick Lee Purdon is an American biomedical engineer whose research focuses on neuroscience, neuroengineering, and clinical applications. He holds the Nathaniel M. Sims Endowed Chair in Anesthesia Innovation and Bioengineering at Massachusetts General Hospital and is an associate professor of anaesthesia at Harvard Medical School. Purdon received his Ph.D. in biomedical engineering from Massachusetts Institute of Technology in 2005. His research in neuroengineering encompasses the mechanisms of anesthesia, Alzheimer’s disease and brain health, anesthesia and the developing brain, neural signal processing, and the development of novel technologies for brain monitoring. He has published over 90 peer-reviewed publications, is an inventor on 16 pending patents, and is a Fellow of the American Institute for Medical and Biological Engineering. Purdon has won many awards, including the prestigious National Institutes of Health Director’s New Innovator Award, and his work has been covered in the popular media, including programs on Radiolab and NPR.
Harris Eyre is an Australian neuroscientist, entrepreneur and author. He is focused on advancing the field of brain capital. It is believed the world is increasingly relying on brain capital, where a premium is put on brain skills and brain health, and that investing in building brain capital is fundamental to meet modern societal challenges and to drive innovation. He is pioneering the brain-positive economic transition which is a global goal to stop and reverse the loss of brain capital.
Elicia Maine is a Canadian academic. She is the W.J. VanDusen Professor of Innovation & Entrepreneurship within Simon Fraser University's Beedie School of Business. She was the founding educational coordinator for New Ventures BC, and the founding Academic Director of Invention to Innovation (i2I), an award-winning graduate program in science & technology commercialization offered in traditional and online formats. Within Simon Fraser University, she serves as Associate Vice President, Knowledge Mobilization & Innovation, providing oversight of SFU Innovates.
{{cite journal}}
: CS1 maint: multiple names: authors list (link){{cite journal}}
: CS1 maint: multiple names: authors list (link)